Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

Author:

Newhouse Rebecca1,Nelissen Ellen2,El-Shakankery Karim Hussien3,Rogozińska Ewelina4,Bain Esme5,Veiga Susana5,Morrison Jo1

Affiliation:

1. Department of Gynaecological Oncology; Musgrove Park Hospital; Taunton UK

2. Department of Gynaecological Oncology; The Royal Marsden; London UK

3. Medical Oncology; University College London Hospitals NHS Trust; London UK

4. The Evidence-Based Medicine Consultancy Ltd; Bath UK

5. Department of Gynaecological Oncology; North Bristol NHS Trust; Bristol UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference277 articles.

1. Apatinib combined with pegylated liposomal doxorubicin (PLD) versus PLD for platinum-resistant recurrent ovarian cancer (APPROVE): a multicenter, randomized, controlled, open-label, phase II trial;Wang;Gynecologic Oncology

2. TLK286 (telcyta) in combination with carboplatin (paraplatin) versus doxil in platinum refractory or resistant ovarian cancer clinicalTrails.gov 2005

3. Phase 3 Study: Canfosfamide (C, TLK286) plus carboplatin (P) vs liposomal doxorubicin (D) as 2nd line therapy of platinum (P) resistant ovarian cancer (OC);Rose;Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I,2007

4. Randomised phase III study of canfosfamide (TLK 286) plus pegylated liposomal doxorubicin (PLD) vs PLD as second-line therapy in platinum (P) refractory or resistant ovarian cancer (OC);Vergote;Journal of Clinical Oncology,2009

5. Randomized phase III study of canfosfamide in combination with pegylated liposomal doxorubicin compared with pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer;Vergote;International Journal of Gynecological Cancer,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3